Castle Biosciences Inc —— 季度现金流量表 (NASDAQ:CSTL) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 531.24 M501.71 M544.73 M562.79 M578.56 M 负债总额 75.4 M61.41 M89.35 M95.74 M107.68 M 权益总额 455.83 M440.31 M455.38 M467.05 M470.87 M 负债及股东权益总额 531.24 M501.71 M544.73 M562.79 M578.56 M 总债务 10.12 M10.03 M10.04 M10.05 M10.16 M 净债务 -456.43 M-450.58 M-454.01 M-479.48 M-472.12 M

新闻

Castle Biosciences: Buying The Remaining DecisionDx-Melanoma Upside (NASDAQ:CSTL)

Castle Biosciences, Inc. (CSTL) Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study Transcript

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

AstraZeneca's Imfinzi Secures Approval for Gastric Cancer in the EU

FDA Approves NVS' Cosentyx in Hidradenitis Suppurativa for Adolescents

United Therapeutics Stock Surges 32% in 6 Months: Here's Why

Beam Therapeutics Stock Surges 23% in 6 Months: What's Driving It?

JNJ Seeks Label Expansion of Multiple Myeloma Drug Tecvayli in the EU

Castle Biosciences首席财务官Stokes Frank出售价值19.2万美元股票

Stokes Frank sells Castle Biosciences (CSTL) stock worth $192k

LLY Wins CHMP Nod for Olumiant's Expanded Use in Alopecia Areata

REGN & SNY's Dupixent Gets CHMP Nod for Pediatric Use in Urticaria